Skip to content

TenaTac

by CuraMedical B.V. Netherlands EUDAMED

Ref TT-12580

EMDN M040503

Overview

The TenaTac medical device is a Class III implantable product used to treat urinary retention. It features an insertable device that delivers medication directly into the bladder, improving urine flow and reducing symptoms of overactive bladder.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-08717903349052 Basic UDI-DIDate17 Aug 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
TenaTac
Model / Reference
TT-12580
Primary DI / UDI-DI
08717903349052
Basic UDI-DI
B-08717903349052
EMDN Code
M040503 Gelatine sponge haemostatic dressings
Device Class
Class III
Market of Registration
Netherlands

Manufacturer details

EUDAMED SRN
NL-MF-000000052

Other devices from CuraMedical B.V.

See all devices from CuraMedical B.V. →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
  • Animal Tissues
Other properties (10)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 69d51bf2-2dd5-435c-9c1e-b4cf770fa599 61 fields · synced 23 Oct 2026